Turn Therapeutics Q3 EPS $(0.21) Misses $(0.09) Estimate
Benzinga Newsdesk 1 hour ago
NewsEarningsEarnings Misses
Turn Therapeutics (NASDAQ:TTRX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.09) by 162.5 percent. This is a 200 percent decrease over losses of $(0.07) per share
Turn Therapeutics (NASDAQ:TTRX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.09) by 162.5 percent. This is a 200 percent decrease over losses of $(0.07) per share from the same period last year.